Neuroimaging and other neurobiological indices in schizophrenia: relationship to measurement of functional outcome.
As understanding of the pathobiology of schizophrenia increases, the challenge is to relate such measures to outcome at a functional level. To consider our current understanding of how neurobiological variables relate to functional outcome and might constitute outcome measures in their own right. Critical appraisal of recent evidence on structural and functional imaging, neurological evaluation, early neurodevelopmental indices, genomics, proteomics, metabolomics and apoptotic mechanisms in relation to outcome. Studies conducted prospectively from the first episode of schizophrenia are generating more reliable findings but currently lack predictive power. Prediction oftransition from 'highrisk' status to first episode has proved somewhat more fruitful, butthe gain has been modest and circumscribed. Our current level of understanding does not yet allow the generation of predictive models on an individual patient basis. Genomic and metabolomic studies hold particular potential for generating clinically meaningful 'biomarkers' but considerable further work is necessary.